Indo Us Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on August 28, 2025.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Indo Us Biotech Limited met on August 28, 2025, and approved key items for the 21st Annual General Meeting (AGM) scheduled for September 30, 2025, at 2:30 PM via video conferencing. The board approved the draft AGM notice, Directors' Report for FY 2024-25, and set the book closure period from September 23 to September 30, 2025. E-voting will be open from September 27 (9:00 AM) to September 29 (5:00 PM), with the cut-off date for voting eligibility set as September 23, 2025. The board also approved the re-appointment of Mr. Jagdish Ajudiya as Managing Director for five years (November 23, 2025, to November 22, 2030), re-appointment of M/s. Amrish Gandhi & Associates as Secretarial Auditor for five years (FY 2025-26 to 2029-30), and M/s. Raj Shah & Associates as Internal Auditor for FY 2025-26.
No major financial or strategic change for shareholders — primarily routine AGM-related approvals and re-appointments of directors and auditors. The re-appointment of the Managing Director for a fresh five-year term provides leadership continuity. Investors should note the book closure dates (September 23-30) as shares cannot be traded during this period if they wish to be eligible for the AGM and e-voting.